Source: Υπουργείο Υγείας (CY) Revision Year: 2021 Publisher: Remedica Ltd, Aharnon Street, Limassol Industrial Estate, 3056 Limassol, Cyprus
Clarem 250 mg film-coated tablets.
Clarem 500 mg film-coated tablets.
| Pharmaceutical Form |
|---|
|
Film-coated tablet. Clarem 250 mg film-coated tablets: Yellow, parallel, capsule shaped, film-coated tablets with Remedica’s logo on both sides. Clarem 500 mg film-coated tablets: Yellow, oval, film-coated tablets, scored on one side and embossed with “CL500” on the other side. The tablet can be divided into equal doses. |
Clarem 250 mg film-coated tablets: Each film-coated tablet contains 250 mg clarithromycin.
Clarem 500 mg film-coated tablets: Each film-coated tablet contains 500 mg clarithromycin.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Clarithromycin |
Clarithromycin is a semi-synthetic derivative of erythromycin A. It exerts its antibacterial action by selectively binding to the 50s ribosomal sub-unit of susceptible bacteria preventing translocation of activated amino acids. It inhibits the intracellular protein synthesis of susceptible bacteria. |
| List of Excipients |
|---|
|
Core: Povidone Coating: Hypromellose |
Clarem 250 mg film-coated tablets: PVC-PVDC/Aluminium blisters. Pack sizes of 14 and 100 film-coated tablets.
Clarem 500 mg film-coated tablets: PVC-PVDC/Aluminium blisters. Pack sizes of 14 and 100 film-coated tablets.
Not all pack sizes may be marketed.
Remedica Ltd, Aharnon Street, Limassol Industrial Estate, 3056 Limassol, Cyprus
Clarem 250 mg film-coated tablets: 19180
Clarem 500 mg film-coated tablets: 19181
Clarem 250 mg film-coated tablets:
Date of first authorization: 12 March 2001
Date of latest renewal: 29 March 2013
Clarem 500 mg film-coated tablets:
Date of first authorization: 13 March 2001
Date of latest renewal: 29 March 2013
| Drug | Countries | |
|---|---|---|
| CLAREM | Cyprus, Hong Kong |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
